Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-22-082226
Filing Date
2022-12-22
Accepted
2022-12-22 16:37:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea170347-defa14a_citius.htm DEFA14A 9135
2 GRAPHIC image_001.jpg GRAPHIC 186553
3 GRAPHIC image_002.jpg GRAPHIC 121719
  Complete submission text file 0001213900-22-082226.txt   435079
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38174 | Film No.: 221482391
SIC: 2834 Pharmaceutical Preparations